Basics Aprea Therapeutics, Inc. IPO Date: September 30, 2019 Sector: Healthcare Industry: Biotech Market Cap: $9.24M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 3.74% Avg Daily Range (30 D): $0.07 | 3.95% Avg Daily Range (90 D): $0.10 | 3.87% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .02M Avg Daily Volume (90 D): .02M Trade Size Avg Trade Size (Sh.): 214 Avg Trade Size (Sh.) (30 D): 213 Avg Trade Size (Sh.) (90 D): 199 Institutional Trades Total Inst.Trades: 119 Avg Inst. Trade: $1.73M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 7.56K         News May 14, 2025 @ 12:00 PM Aprea Therapeutics Reports First Quarter 2025 Fina... Source: N/A Jun 21, 2024 @ 12:00 PM Aprea Therapeutics to Host Virtual KOL Event on AP... Source: Aprea Therapeutics Jun 17, 2024 @ 12:30 PM Aprea Therapeutics Announces First Patient Dosed i... Source: Aprea Therapeutics May 28, 2024 @ 12:45 PM Aprea Therapeutics Announces that Safety Review Co... Source: Aprea Therapeutics May 13, 2024 @ 8:01 PM Aprea Therapeutics to Attend the 2024 RBC Capital ... Source: Aprea Therapeutics Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.35 $-.66 $-.47 Diluted EPS $-2.45 $-.66 $-.57 Revenue $ 1.28M $ .16M $ .21M Gross Profit $ $ $ Net Income / Loss $ -14.08M $ -3.93M $ -2.89M Operating Income / Loss $ -15.26M $ -4.09M $ -3.23M Cost of Revenue $ $ $ Net Cash Flow $ -9.52M $ M $ -3.38M PE Ratio     Splits Feb 13, 2023:   1:20 Dec 27, 2018:   1:1000 Sep 13, 2011:   1:500